Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT03932838

Descriptive Study of Multiligamentary Reconstruction of the Knee

Led by Versailles Hospital · Updated on 2026-03-17

80

Participants Needed

1

Research Sites

913 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Evaluation of clinical results and postoperative laxity after single-stage reconstruction of multiligamentous lesions of the knee. Comparison of two types of transplant: allograft versus autograft. There is currently little data in the clinical outcome literature after allograft reconstruction. There is one study reporting postoperative laxity assessed by dynamic radiography in the four planes (anterior, posterior, varus, valgus). No study compares postoperative laxity after allograft versus autograft reconstruction.

CONDITIONS

Official Title

Descriptive Study of Multiligamentary Reconstruction of the Knee

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients operated for one-time allograft or autograft reconstruction of multiligamentous knee injury
  • Older than 18 years old
Not Eligible

You will not qualify if you...

  • Neurological or vascular injury during trauma
  • Fracture of the femur or both bones of the leg
  • Ligamentous lesion on the contralateral knee
  • History of surgery on the affected knee

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

CH de Versailles

Le Chesnay, France

Actively Recruiting

Loading map...

Research Team

N

Nicolas Pujol

CONTACT

L

Laure Morisset

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

BASIC_SCIENCE

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here